| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |